Allogene Therapeutics, Inc.
← Back to ALLO Overview

Allogene Therapeutics, Inc. (ALLO)

Solvency & Capital Structure

Total Debt

$81.1M

Net Debt

-$185.8M

Allogene Therapeutics, Inc. currently has $81.1M in total debt. Net debt is -$185.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

ALLOQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.080.27-0.19Net Cash0.4020.5%
2025-12-310.080.25-0.17Net Cash0.4220.0%
2025-09-300.090.25-0.17Net Cash0.4419.4%
2025-06-300.080.27-0.19Net Cash0.4716.8%
2025-03-310.080.28-0.20Net Cash0.5116.0%
2024-12-310.090.29-0.20Net Cash0.5516.5%
2024-09-300.090.29-0.21Net Cash0.5914.5%
2024-06-300.090.44-0.35Net Cash0.6514.6%
2024-03-310.100.38-0.29Net Cash0.5916.3%
2023-12-310.100.45-0.35Net Cash0.6414.8%
2023-09-300.100.47-0.37Net Cash0.7113.6%
2023-06-300.090.49-0.40Net Cash0.7711.9%
2023-03-310.100.47-0.37Net Cash0.7513.3%
2022-12-310.100.52-0.42Net Cash0.8212.3%
2022-09-300.100.55-0.46Net Cash0.8910.9%
2022-06-300.100.49-0.39Net Cash0.9510.4%
2022-03-310.070.45-0.38Net Cash0.967.2%
2021-12-310.070.46-0.38Net Cash1.057.0%
2021-09-300.050.48-0.43Net Cash1.084.7%
2021-06-300.050.59-0.54Net Cash1.134.5%
2021-03-310.050.70-0.65Net Cash1.184.4%
2020-12-310.050.83-0.77Net Cash1.234.4%
2020-09-300.050.84-0.79Net Cash1.224.2%
2020-06-300.050.90-0.85Net Cash1.264.1%
2020-03-310.050.49-0.44Net Cash0.697.5%
2019-12-310.050.53-0.48Net Cash0.727.4%
2019-09-300.040.50-0.46Net Cash0.705.4%
2019-06-300.030.65-0.62Net Cash0.734.8%
2019-03-310.030.47-0.43Net Cash0.754.6%
2018-12-310.030.72-0.69Net Cash0.774.5%
2018-09-300.170.24-0.08Net Cash0.4438.0%
2018-06-300.000.29-0.29Net Cash0.300.0%